2022³â Á¦19Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ,°æ±âÁöȸ Çмú´ëȸ : 2022-12-03±³À°ÀÏÀÚ : 2022-12-03
±³À°Àå¼Ò : ºÐ´ç¼¿ï´ëÇб³º´¿ø ÇコÄɾîÇõ½ÅÆÄÅ©¹Ì·¡È¦(4F)
±³À°ÁÖÁ¦ :
2022³â Á¦19Â÷ ´ëÇѺñ´¢ÀÇÇÐȸ ÀÎõ,°æ±âÁöȸ Çмú´ëȸÁÖÃÖ±â°ü : ´ëÇѺñ´¢ÀÇÇÐȸ(19.2 ¸íĪº¯°æ ´ëÇѺñ´¢±â°úÇÐȸ)
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÀÎõ°æ±âÁöȸ
´ã´çÀÚ : À̼¼Èñ
¿¬¶ôó : 02-573-8190
À̸ÞÀÏ :
urology@urology.or.kr ±³À°Á¾·ù : ºñ´¢ÀÇÇаú
Âü¼®¿¹»óÀοø : 60¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª :
°æ±âµµ±³À°½Ã°£ : 4 ½Ã°£ 0ºÐ
¼¼ºÎ¼ö°·á : 0¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 12:30~13:00 µî·Ï ()
±âŸ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 13:00~13:10 Àλ縻 ()
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 13:10~13:25 Impact of incontinence surgery in female sexual function À̼ҿ¬(ÇѾçÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 13:25~13:40 Bladder inflammation: intravesical therap ÇÑÁö¿¬(¼º³²ÀÇ·á¿ø)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 13:40~13:55 Recent novel devices in urology ÀÌ¿µÁÖ(Â÷ÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 13:55~14:10 Update on surgical treatment of BPH Á¤Áؼ¼(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 14:10~14:25 The optimal approach to identify success and failure after focal therapy for prostate cancer ±èÁ¤±Ç(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 14:25~14:40 The optimal multimodal approach for high risk prostate cancer; combination or sequencing ¹ÚÀç¿ø(Àϻ꺴¿ø)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 14:40~14:55 Place of bilateral orchiectomy for prostate cancer in the present era ÃÖÁß¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 14:55~15:10 Metastasis-directed therapy in oligometastatic prostate cancer ±èÅÂÇå(Â÷ÀÇ´ë)
ÈÞ½Ä 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 15:10~15:30 ´Üü»çÁø ¹× Coffee brea ()
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 15:30~15:45 Bladder preservation strategies for MIBC ÃÖ¿µÈ¿(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 15:45~16:00 Biomarkers in advanced urothelial cancer ¿ÀÁ¾Áø(¼¿ïÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 16:00~16:15 Biopsy or not biopsy for small renal masses ½É¸í¼±(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 16:15~16:30 A few unanswered questions regarding the ¡®modern¡¯ RCC management in a community hospital: The call of wisdom in a real clinical practice ±èÁ¤ÁØ(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 16:30~16:45 Commensal gut microbiota and androgen biosynthesis in prostate cancer ±è¿õºó(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 16:45~17:00 STD guideline update ÃÖâÀÏ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 17:00~17:15 Medical expulsive therapy for ureter stone: Current role and future prospect °µ¿Çõ(ÀÎÇÏÀÇ´ë)
±³À°½Ã°£ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 17:15~17:30 Tips and Tricks of RIRS Á¤Áø¿ì(°¡Å縯°üµ¿ÀÇ´ë)
±âŸ 12-03 ºÐ´ç¼¿ï´ëº´¿ø ÇコÄɾîÇõ½ÅÆÄÅ© ¹Ì·¡È¦ (4F) 17:30~18:00 ÀÎõ-°æ±âÁöȸ ÃÑȸ & Closing ()